Kavitha Muralidharan, Divyansh Agarwal, Ali Naji, and Vijay G. Bhoj Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of Alloimmunity , The Journal of Immunology, 209(10): 2022,1811-1816
Ellis GI, Coker KE, Winn DW, Deng MZ, Shukla D, Bhoj V, Milone MC, Wang W, Liu C, Naji A, Duran-Struuck R, Riley JL. Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque , Cell Rep Med, 3(5): 2022,100614
Lederer K, Bettini E, Parvathaneni K, Painter MM, Agarwal D, Lundgreen KA, Weirick M, Muralidharan K, Castaño D, Goel RR, Xu X, Drapeau EM, Gouma S, Ort JT, Awofolaju M, Greenplate AR, Le Coz C, Romberg N, Trofe-Clark J, Malat G, Jones L, Rosen M, Weiskopf D, Sette A, Besharatian B, Kaminiski M, Hensley SE, Bates P, Wherry EJ, Naji A, Bhoj V, Locci M. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals , Cell, 185(6): 2022,1008-1024
Durgin JS, Thokala R, Johnson L, Song E, Leferovich J, Bhoj V, Ghassemi S, Milone M, Binder Z, O'Rourke DM, O'Connor RS. Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase , Mol Ther, 30(3): 2022,1201-1214
Parvathaneni K, Torres-Rodriguez K, Meng W, Hwang WT, Frey N, Naji A, Bhoj VG. SARS-CoV-2 Spike-Specific T-Cell Responses in Patients With B-Cell Depletion Who Received Chimeric Antigen Receptor T-Cell Treatments , JAMA Oncol, 8(1): 2022,164-167
Mireia Uribe-Herranz, Silvia Beghi, Marco Ruella, Kalpana Parvathaneni, Silvano Salaris, Nektarios Kostopoulos, Subin S. George, Stefano Pierini, Guido Ghirardi, Kimberly V. Amelsberg, Yong Gu Lee, Raymone Pajarillo, Caroline Markmann, Bevin McGettigan-Croce, Noelle Frey, Simon F. Lacey, John Scholler, Khatuna Gabunia, Gary Wu, Elise Chong, David L. Porter, Carl H. June, Stephen J. Schuster, Vijay Bhoj and Andrea Facciabene Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy , Molecular Therapy: 2022
Markmann C, Bhoj VG. On the road to eliminating long-lived plasma cells-"are we there yet?" , Immunol Rev, 303(1): 2021,154-167
Caroline Markmann, Vijay G Bhoj On the road to eliminating long-lived plasma cells-"are we there yet?" , Immunological Reviews, 303(1): 2021,154-167
Kong W, Dimitri A, Wang W, Jung IY, Ott CJ, Fasolino M, Wang Y, Kulikovskaya I, Gupta M, Yoder T, DeNizio JE, Everett JK, Williams EF, Xu J, Scholler J, Reich TJ, Bhoj VG, Haines KM, Maus MV, Melenhorst JJ, Young RM, Jadlowsky JK, Marcucci KT, Bradner JE, Levine BL, Porter DL, Bushman FD, Kohli RM, June CH, Davis MM, Lacey SF, Vahedi G, Fraietta JA. BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia , J Clin Invest, 131(16): 2021,e145459
Faude S, Wei J, Muralidharan K, Xu X, Wertheim G, Paessler M, Bhoj VG, Grupp SA, Maude SL, Rheingold SR, Pillai V. Absolute lymphocyte count proliferation kinetics after CAR T-cell infusion impact response and relapse , Blood Adv, 5(8): 2021,2128-2136
